Community Engagement and Informed Consent in the International HapMap ProjectRotimi C.a · Leppert M.b · Matsuda I.e · Zeng C.h · Zhang H.i · Adebamowo C.j · Ajayi I.j · Aniagwu T.j · Dixon M.b · Fukushima Y.f · Macer D.k · Marshall P.d · Nkwodimmah C.j · Peiffer A.b · Royal C.a · Suda E.g · Zhao H.h · Wang V.O.c · McEwen J.c
aNational Human Genome Center, Howard University, Washington, D.C., bDepartment of Human Genetics, University of Utah, Salt Lake City, Utah, cNational Human Genome Research Institute, US National Institutes of Health, Bethesda, Md., and dDepartment of Bioethics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA; eHealth Sciences University of Hokkaido, Hokkaido, fDepartment of Medical Genetics, Shinshu University School of Medicine, Matsumoto, and gUniversity of Tsukuba, Eubios Ethics Institute, Tsukuba Science City, Japan; hBeijing Genomics Institute, Chinese Academy of Sciences, and iBeijing Normal University, Beijing, China; jUniversity of Ibadan College of Medicine, Ibadan, Oyo State, Nigeria; kUnited Nations Educational, Scientific and Cultural Organization (UNESCO), Prakanong, Bangkok, Thailand
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
The International HapMap Consortium has developed the HapMap, a resource that describes the common patterns of human genetic variation (haplotypes). Processes of community/public consultation and individual informed consent were implemented in each locality where samples were collected to understand and attempt to address both individual and group concerns. Perceptions about the research varied, but we detected no critical opposition to the research. Incorporating community input and responding to concerns raised was challenging. However, the experience suggests that approaching genetic variation research in a spirit of openness can help investigators better appreciate the views of the communities whose samples they seek to study and help communities become more engaged in the science.
© 2007 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.